Pharma & Biotech M&A Report 2011

28.06.2011

The Pharmaceutical industry is undergoing major fundamental transitions. Lack of new drugs and price pressure by the payer groups decrease margins. To seize opportunities provided by the emerging markets and new technologies, Pharma companies may have to adopt their business models. Find insights on these and other major issues in the IMAP report on the global Pharma and Biotech industry which you can download here for free.